AMR news related to Smart Innovations

For scientists, researchers, and innovators committed to staying at the forefront of antimicrobial resistance, AMR Insights provides the most comprehensive, up-to-date overview of global news and breakthroughs. Access cutting-edge research, expert insights, and the latest developments to fuel your work and accelerate progress in the fight against AMR.


20 December 2024

Fighting Antimicrobial Resistance in Developing Countries: Innovative Approaches and Challenges

19 December 2024

A Screen of Traditional Chinese Medicinal Plant Extracts Reveals 17 Species with Antimicrobial Properties

16 December 2024

Systematic mapping of antibiotic cross-resistance and collateral sensitivity with chemical genetics

14 December 2024

Advancements of paper-based sensors for antibiotic-resistant bacterial species identification

11 December 2024

Harnessing Vernon Smith’s Experimental Economics to Combat Antimicrobial Resistance in Sweden: A Simulation-Based Analysis

9 December 2024

Nanotechnology in Targeted Delivery of Antimicrobials and Overcoming Resistance

6 December 2024

Machine learning-based prediction of antibiotic resistance in Mycobacterium tuberculosis clinical isolates from Uganda

5 December 2024

Recent Applications of Artificial Intelligence in Discovery of New Antibacterial Agents

4 December 2024

Tuning antibacterial efficacy against Pseudomonas aeruginosa by using green AgNPs in chitosan thin films as a plastic alternative

3 December 2024

Antibiotic susceptibility testing usingminimum inhibitory concentration (MIC) assays

2 December 2024

DnnARs: An Artificial Intelligence Technique for Prediction of Antimicrobial Resistant Strains in E. coli Bacteria Causing Urine Tract Infection

29 November 2024

Evaluation of DNA extraction kits for long-read shotgun metagenomics using Oxford Nanopore sequencing for rapid taxonomic and antimicrobial resistance detection

28 November 2024

CRISPR-Cas Systems in the Fight Against Antimicrobial Resistance: Current Status, Potentials, and Future Directions

24 November 2024

Talent loss and market issues are a major threat to addressing global AMR crisis

23 November 2024

Personalised antimicrobial susceptibility testing with clinical prediction modelling informs appropriate antibiotic use

18 November 2024

Light-Activable Inhibitor Overcomes Antimicrobial Resistance and Regulates Antibacterial Activity

18 November 2024

Using digital health to address antimicrobial resistance

18 November 2024

Discovery of new AMR drugs targeting modulators of antimicrobial activity using in vivo silkworm screening systems

12 November 2024

Next-generation rapid phenotypic antimicrobial susceptibility testing

8 November 2024

Antibiotic susceptibility testing using minimum inhibitory concentration (MIC) assays

8 November 2024

IFPMA-INTERFARMA-FIFARMA statement on the Rio de Janeiro Declaration of the G20 Health Ministers

26 October 2024

Enhanced automated detection of outbreaks of a rare antimicrobial-resistant bacterial species

24 October 2024

Nanomedicines as a cutting-edge solution to combat antimicrobial resistance

24 October 2024

Addressing urgent priorities in antibiotic development: insights from WHO 2023 antibacterial clinical pipeline analyses

24 October 2024

Development of a new Acinetobacter baumannii pneumonia rabbit model for the preclinical evaluation of future anti-infective strategies

23 October 2024

Systematic discovery of antibacterial and antifungal bacterial toxins

22 October 2024

Standardisation of high throughput microdilution antifungal susceptibility testing for Candida albicans and Cryptococcus neoformans

21 October 2024

GPT-4-based AI agents—the new expert system for detection of antimicrobial resistance mechanisms?

21 October 2024

New WHO report presents progress in G7 countries in tackling antibiotic pipeline crisis

18 October 2024

Using interpretable machine learning to predict bloodstream infection and antimicrobial resistance in patients admitted to ICU: Early alert predictors based on EHR data to guide antimicrobial stewardship

18 October 2024

WHO EMRO RC71: Promoting collaborative action to accelerate the response to antimicrobial resistance in the Eastern Mediterranean Region

17 October 2024

Unveiling Encrypted Antimicrobial Peptides from Cephalopods’ Salivary Glands: A Proteolysis-Driven Virtual Approach

17 October 2024

Telemedicine-based antibiotic stewardship program in pediatrics: study protocol of a stepped wedge cluster randomized trial—the TeleKasper study

17 October 2024

C-CAMP partners with ICARS to support innovative One Health solutions for AMR challenges

14 October 2024

Hospital antimicrobial stewardship team perceptions and usability of a computerized clinical decision support system

14 October 2024

Predicting future hospital antimicrobial resistance prevalence using machine learning

11 October 2024

New research network unites Oxford University’s global fight against antimicrobial resistance

9 October 2024

A global genome dataset for Salmonella Gallinarum recovered between 1920 and 2024

7 October 2024

Updated EUP OHAMR Strategic Research and Innovation Agenda

3 October 2024

PACE has opened a new call for proposals: 2024 Diagnostic Innovations

3 October 2024

Proof of concept study on early forecasting of antimicrobial resistance in hospitalized patients using machine learning and simple bacterial ecology data

26 September 2024

Prophages are Infrequently Associated With Antibiotic Resistance in Pseudomonasaeruginosa Clinical Isolates

25 September 2024

The AMR Accelerator: from individual organizations to efficient antibiotic development partnerships

25 September 2024

BARDA awards $29 million to Basilea Pharmaceutica for first-in-class anti-fungal treatments

23 September 2024

The time to address the antibiotic pipeline and access crisis is now

23 September 2024

Phenotypic and genotypic perspectives on detection methods for bacterial antimicrobial resistance in a One Health context: research progress and prospects

13 September 2024

A randomized controlled trial investigating experiential virtual reality communication on prudent antibiotic use

13 September 2024

F2G Announces $100 Million Financing to Advance Late-Stage Development and Commercialization of Novel Antifungal Drug Candidate Olorofim in the US

12 September 2024

Future Prospective of Omics-System Biology to Control AMR: Recommendations and Directions

11 September 2024

Assessment of the antibacterial and antioxidant activities of seaweed-derived extracts



What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed